resistance mechanisms (6). To determine if systemic effects Canada M5S 3E2 could account for resistance, two groups performed similar 2 To whom correspondence should be addressed transplantation experiments (8, 9) . In one set of experiments, Resistance to chemically-induced mammary tumors in the Cop mammary epithelial cells, susceptible NSD mammary Copenhagen rat is well defined, but the mechanism of epithelial cells, or a mixture of the two preparations were resistance has yet to be determined. We have tested whether transplanted into the cleared mammary fat pads of CopϫNSD or not Copenhagen rat resistance is dependent on T-cells, F1 animals. The transplanted cells were then directly treated since several lines of evidence supported an involvement by dusting with DMBA (8). No tumors developed if Cop cells of the immune system. We crossed Copenhagen rats with were transplanted, but tumors developed if NSD or a mixture an athymic nude rat to produce F1s, that were interbred of Cop and NSD mammary epithelial cells were transplanted. to produce F2 animals, some of which were athymic with It was concluded that resistance must be due to an autosomal partial Copenhagen rat background. A comparison of the dominant tumor suppressor gene that acts mainly within the mammary tumor incidences between the nude athymic F2
Introduction
The binding of peptide fragments to specific MHC molecules Chemically-induced mammary tumors in the rat have been is dependent upon the sequence of the peptide being presented particularly useful in furthering our understanding of human (10) . Since the NSD rat expresses a different set of MHC breast cancer development (1) (2) (3) . Tumors can be readily molecules from the Cop rat (RT-1 b and RT-1 a haplotypes, induced in 50 day old virgin female rats by a single injection respectively) (11, 12) , the NSD may be incapable of presenting of a chemical carcinogen such as N-methyl-N-nitrosourea the peptide fragment. In this case, no CTLs would recognize (MNU*) (1) or 7,12-dimethylbenz[a]anthracene (DMBA) (4) . and lyse the preneoplastic cells, thus allowing them to develop For example, following treatment with MNU, mammary adenointo tumors. A potential antigen in the MNU-induced tumors carcinomas develop within 4-6 months in almost 100% of the could be the p21 ras protein derived from the Ha-ras oncogene. animals. More than 85% of these tumors harbor the Ha-ras
In a variety of cellular systems, peptide fragments of mutated oncogene (5) .
p21 ras have been shown to be presented via the MHC and In this tumor model, susceptibilty varies considerably among recognized by T-cells (13) (14) (15) . Since inheritence of the MHC different strains of rat. Many strains such as Wistar-Furth is co-dominant (16), an F1 hybrid would express both the Cop (WF), Buffalo (Buf/N), and inbred Sprague-Dawley (NSD) and NSD MHC molecules. Thus, if Cop rats are resistant rats are highly susceptible to carcinogen treatment, developing because of antigen presentation by preneoplastic mammary multiple tumors following treatment (6) . Some strains, such epithelial cells, then CTLs from a CopϫNSD F1 animal would as the Fischer 344 rat, develop between one and two tumors also recognize and eliminate the transplanted Cop cells in an per animal on average, and are classified as intermediate in MHC-restricted manner. These F1 CTLs, however, would be their sensitivity (6) . Finally, a few strains such as Copenhagen unable to eliminate NSD cells, since they would not present (Cop) (6) and Wistar-Kyoto (7) rats are resistant, rarely the antigen, and do not express the RT1 a MHC. Therefore, developing tumors after treatment.
NSD preneoplastic mammary epithelial cells would develop into tumors in an F1 animal in this model. are as shown in Table I . The resistance gene is T-cell dependent, a normal immune system (Nu for normal, nu for nude athymic We present here experiments designed to show in a definitive manner whether elimination of preneoplastic cells by CTLs in phenotype) is required for resistance. There are 16 possible genotypes in the F2 population. One quarter of the rats will the Cop rat could account for its resistance to mammary tumorigenesis. We crossed female Cop rats with a male athymic be nude (nu/nu) and therefore susceptible. Three quarters of the F2 rats will be non-nude (Nu/Nu or Nu/nu), and, unlike nude rat to produce F1 animals that were interbred to produce F2 rats. The F2 rats were treated with MNU to determine their the nudes, will show a distribution of resistance and susceptibilty. One quarter of the non-nude rats will have the RR susceptibilty to mammary tumor development. Our experiments show that the T-cell component of the immune system genotype and will therefore be resistant like the parental Cop strain. The non-nude rats that are heterozygous at the resistance does not play a role in Cop resistance.
locus ( for the nude F2s in this model.
Carcinogen treatment
If we assume the parental nude and Cop rats carry a T-cell
We administered 50 mg/kg MNU (Ash-Stevens, MI) dissolved in acidified dependent resistance gene, then the expected genotypes of the normal saline at a concentration of 10 mg/ml to six Buf/N, 24 F2 nude, and F2 animals are shown in Table II Finally, if T-cell immunity is not involved in resistance, the the 50 day protocol, the study was terminated 8 months post-MNU for the tumor incidences in the two groups should be identical and nudes and non-nudes, and 7 months post-MNU for the Buf/N controls. For dependent on the phenotype of the parental nude.
the 21 day protocol, the study was terminated 5-6 months post-MNU for all groups, except the nudes, which were killed 8 months post-MNU. Portions of There is some recent evidence to suggest that the resistance all tumors were fixed in 10% formalin for histopathological analysis.
of the Cop rat may be a polygenic trait (24). The conclusions and susceptible Buf/N rats with 50 mg/kg MNU when the rats were 50 days of age, according to the standard protocol for Results and discussion mammary tumor induction (1). We also used a newly described protocol in which nude and non-nude F2 animals, resistant Cop rats were bred with athymic nude rats in order to produce F2 animals that were either athymic (nude) or normal (nonCop rats, and susceptible WF rats were injected at 21 days of age with 50 mg/kg of MNU. This protocol results in rapid nude), both phenotypes having a partial Cop background. The rationale for this experiment was that the mammary tumor mammary tumor development in susceptible rats (22). The results of these experiments are shown in Figures 2 and 3 . incidences in these F2 animals will depend on whether there is a Cop rat resistance gene with a mode of action that depends Several of the tumors were selected for histopathological analysis and were shown to be adenocarcinomas, as previously on T-cells, and whether the parental nude rat carries this resistance gene. If such a T-cell-dependent gene exists, all described (3,22). With both protocols, there was no significant difference in tumor incidences or average number of tumors per rat between the nude and non-nude littermates. This shows that T-cells are not involved in resistance. Furthermore, it is clear that in both experiments, the mammary tumor incidence and average number of tumors per rat in the F2 animals was essentially zero, whereas the susceptible control rats developed a high incidence of tumors. As outlined previously, if the parental nude had been either highly susceptible or of intermediate susceptibilty to mammary carcinogenesis, the tumor incidences in the F2s would have been much higher than those observed. Thus our results show that the parental nude rat is resistant to MNU-induced mammary tumorigenesis. The nude rat is derived from outbred hooded rats from the Rowett Research Institute (25) that have not been reported to be resistant. The nude rat is the fifth rat strain we now know to be resistant to chemically induced tumors, along with Cop, Wistar-Kyoto (6), spontaneous hypertensive (26), and feral rats (6) .
It is unclear whether the resistance of the nude rat, or any of the other resistant strains, is due to the same mechanism as in the Cop rat. Two pieces of evidence, however, support a are resistant to MNU-induced mammary tumors, indicating that neither of these strains is resistant as a result of a defect in the enzymes of drug metabolism, since MNU is a direct Also of interest are several of the results of experiments in which the rats were injected at 21 days of age. This protocol acting carcinogen. Second, we have recently shown that Cop rats are resistant to the development of chemically induced is reported to give rise to mammary tumors in a majority of treated Sprague-Dawley rats within 1 month of treatment (22). hepatic preneoplastic lesions using a resistant hepatocyte protocol (27) . The male nude rats from the breeding experiWhile most of the susceptible WF rats we used as controls did develop tumors, they did not appear until 2-3 months ments outlined above were also resistant to the development of hepatic preneoplasia using the same protocol (data not after MNU treatment. It seems likely, therefore, that the latency of mammary tumor development in susceptible rats injected shown), indicating that the resistance gene(s) of the nude rat may be similar to that of the Cop rat. Even if the resistance at 21 days of age is much more strain dependent than in the standard 50 day protocol. Furthermore, the 20% tumor of the Cop and nude rats does not involve the same gene(s), our breeding experiments would have been able to determine incidence in the Cop rats treated at 21 days of age was much higher than expected. Since we have shown that Cop rats if Cop rat resistance is T-cell dependent; the tumor incidence in the F2 nudes would have been significantly higher (25%) treated with MNU as neonates have a 28% incidence of mammary tumors (17), the present results suggest that Cop than the tumor incidence in their non-nude littermates (~6%). 
